Biological Material Transfer Agreement Template for Australia

When your organization needs to transfer biological materials for research or commercial purposes, a Biological Material Transfer Agreement (MTA) provides the legal framework to protect both parties' interests. This contract ensures that your biological material transfers comply with Australian federal and state regulations while establishing clear terms for material usage, intellectual property rights, and research limitations.

When do you need this document?

You need an MTA whenever your organization transfers biological materials such as cell lines, plasmids, antibodies, tissue samples, or genetic resources. This applies whether you're a university sharing research materials with industry partners, a biotechnology company providing samples to contract research organizations, or a government research agency collaborating with international institutions. The agreement is essential for both incoming and outgoing transfers, ensuring proper documentation for regulatory compliance and protecting your organization's intellectual property rights.

Key legal considerations

Your MTA must clearly define the transferred material, permitted uses, and restrictions on commercial applications. Include specific provisions for intellectual property ownership, particularly regarding any derivatives or modifications created from the original material. Address publication rights and confidentiality requirements to protect sensitive research information. Establish liability and indemnification clauses to protect both parties from potential damages. Include termination provisions that specify what happens to remaining materials and any derivatives upon agreement conclusion. Consider including provisions for third-party transfers and sublicensing to maintain control over material distribution.

Legal requirements in Australia

Under the Gene Technology Act 2000, you must ensure compliance with biosafety requirements if transferring genetically modified organisms or related materials. The Biosecurity Act 2015 mandates proper permits and quarantine procedures for importing or exporting biological materials. State-specific Human Tissue Acts govern transfers involving human biological materials, requiring ethical approval and consent documentation. Your agreement must acknowledge the Convention on Biological Diversity requirements for access and benefit-sharing of genetic resources. Include provisions ensuring compliance with National Health and Medical Research Council guidelines for research ethics. The Patents Act 1990 implications should be addressed regarding any intellectual property rights in the transferred materials or resulting research outcomes.